Exercise Intervention (HIIT program and resistance training) for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Roswell Park Cancer Institute, Buffalo, NYBreast CancerExercise Intervention (HIIT program and resistance training) - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial looks at whether exercise can help improve the health and quality of life of breast cancer survivors.

Eligible Conditions
  • Breast Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: At 12 weeks

At 12 weeks
Proportion of randomized patients who are still on study at the end of the 12 week intervention
Week 12
Body composition
Cardiovascular fitness
Cognitive function
Mitochondrial function
Quality of life
Stress and immune function biomarkers
Up to 12 weeks
Adherence rate in each of the active intervention arms

Trial Safety

Trial Design

5 Treatment Groups

Arm IV (supervised moderate intensity walking program)
1 of 5
Arm V (usual physical activity)
1 of 5
Arm I (home-based walking program, resistance training)
1 of 5
Arm II (home-based Zumba program, resistance training)
1 of 5
Arm III (HIIT, resistance training)
1 of 5

Active Control

Experimental Treatment

190 Total Participants · 5 Treatment Groups

Primary Treatment: Exercise Intervention (HIIT program and resistance training) · No Placebo Group · N/A

Arm I (home-based walking program, resistance training)Experimental Group · 7 Interventions: Exercise Intervention (HIIT program and resistance training), Exercise Intervention (home walking program and resistance training), Quality-of-Life Assessment, Laboratory Biomarker Analysis, Informational Intervention, Monitoring Device, Questionnaire Administration · Intervention Types: Behavioral, Behavioral, Other, Other, Other, Device, Other
Arm II (home-based Zumba program, resistance training)Experimental Group · 6 Interventions: Quality-of-Life Assessment, Laboratory Biomarker Analysis, Exercise Intervention (home-based Zumba program and resistance training), Informational Intervention, Monitoring Device, Questionnaire Administration · Intervention Types: Other, Other, Behavioral, Other, Device, Other
Arm III (HIIT, resistance training)Experimental Group · 5 Interventions: Exercise Intervention (HIIT program and resistance training), Quality-of-Life Assessment, Informational Intervention, Monitoring Device, Questionnaire Administration · Intervention Types: Behavioral, Other, Other, Device, Other
Arm IV (supervised moderate intensity walking program)
Behavioral
ActiveComparator Group · 1 Intervention: Exercise Intervention (HIIT program and resistance training) · Intervention Types: Behavioral
Arm V (usual physical activity)
Other
ActiveComparator Group · 1 Intervention: Best Practice · Intervention Types: Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Monitoring Device
2018
Completed Phase 2
~2260

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at 12 weeks

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
381 Previous Clinical Trials
29,575 Total Patients Enrolled
10 Trials studying Breast Cancer
1,638 Patients Enrolled for Breast Cancer
Tracey L O'ConnorPrincipal InvestigatorRoswell Park Cancer Institute

Eligibility Criteria

Age Any Age · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You do not meet the U.S. Center for Disease Control and Prevention's guidelines for physical activity, which recommend at least 150 minutes of moderate-intensity exercise per week.
You are able to safely participate in low to moderate intensity physical activity according to the American College of Sports Medicine guideline.

Frequently Asked Questions

How many participants are being included in this experiment?

"Affirmative. According to clinicaltrials.gov, the trial initially posted on October 6th 2017 is currently recruiting participants. 190 individuals will be recruited from a single centre for this study which was last updated on July 28th 2022." - Anonymous Online Contributor

Unverified Answer

Are there any vacancies for participation in this experiment?

"This clinical trial is actively recruiting, as evidenced by its update on July 28th 2022. Initially posted on October 6 2017, the research team are currently searching for suitable participants." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.